Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
12 hedge funds and large institutions have $2.39M invested in Vaccinex, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 9 closing their positions.
342% more capital inflows, than outflows
Capital inflows: $2.29M | Capital outflows: $517K
6.82% less ownership
Funds ownership: 33.01% → 26.19% (-6.8%)
29% less funds holding
Funds holding: 17 → 12 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
+$1.26M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.01M |
| 3 |
Morgan Stanley
New York
|
+$9.64K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$4.94K |
| 5 |
TC
Tacita Capital
Toronto,
Ontario, Canada
|
+$1.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$435K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$32.1K |
| 3 |
Renaissance Technologies
New York
|
-$21K |
| 4 |
Two Sigma Investments
New York
|
-$10.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$10.7K |
VCNX Hedge Fund Activity: Q1 2024 in Review
12 of the 6,963 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q1 2024, worth a combined $2.39M — up 124% from $1.07M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VCNX and 4 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 8 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.26M. The largest seller was Worth Venture Partners, exiting entirely with an estimated $435K sold.
- 12 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q1 2024, down from 17 in Q4 2023.
- Funds reported $2.39M of Vaccinex, Inc. Common Stock stock for Q1 2024, up 124% quarter-over-quarter.
- 4 funds opened new Vaccinex, Inc. Common Stock positions in Q1 2024 and 9 closed out, a net change of -5 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q1 2024 was Armistice Capital, an estimated $1.26M added.
- The largest Vaccinex, Inc. Common Stock seller in Q1 2024 was Worth Venture Partners, an estimated $435K sold.
Based on aggregated 13F filings for Q1 2024.